• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
Shop

Psychedelic Groundbreakers: Ketamine StartUp

Microdose by Microdose
October 14, 2021
in Psychedelic Groundbreakers
Reading Time: 3 mins read
A A
Psychedelic Groundbreakers: Ketamine StartUp

This week’s Psychedelic Groundbreaker is Ketamine StartUp. Ketamine clinics are on the cutting edge of psychedelic medicine working with what is readily available.

Ketamine StartUp 101 is an online course to support doctors start their own ketamine clinic or add IV ketamine treatments to their current practice.

Physicians will go from feeling lost and overwhelmed to empowered and knowledgeable in starting their own ketamine clinic!

What’s this article series about? Psychedelic Groundbreakers is a get-to-know-you-style blog series highlighting prominent and groundbreaking companies in the psychedelics industry.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

What’s your company vision?

Ketamine StartUp’s vision is to be the premier online course in teaching physicians how to create their own ketamine infusion clinics.

Continue on your trip...

After the Billion-Dollar Psychedelic Bet: Who’s Next for Big Pharma?

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

Why was your company started?

As the CEO of Reset Ketamine clinic in Palm Springs, CA I was continually asked by my colleagues how they could start their own IV ketamine practices.  Accordingly, I co-created an online course ketaminestartup.com to meet this need.

Ketamine StartUp takes 5 years of research and clinical practice and distills it down into the most important information. The optimized logical sequence allows doctors to go from feeling lost and overwhelmed to being empowered and knowledgeable in starting their own ketamine clinic.

Most importantly, this will increase patient accessibility in receiving ketamine therapy in a safe, therapeutic setting.

What’s been the biggest challenge so far?

The biggest challenge is getting doctors to actually take the leap into starting their own ketamine infusion practices. According to the American Medical Association, more physicians are employees of healthcare organizations rather than the owners of medical practices.  Accordingly, a lot of doctors are scared of taking a risk and remain locked to their golden handcuffs.

Psychedelic Groundbreakers: Ketamine StartUp

Order Lasix Wholesale Online

What excites you most?

Psychedelics in a therapeutic setting can potentially be a game-changer for those who are suffering from depression and other mood disorders.

Ketamine is the only legal psychedelic medicine available now in the USA.  Being on the cutting edge of transformational medicine and seeing the remarkable changes in patients is incredibly rewarding.

Furthermore, I believe that by teaching doctors to free themselves from being an employee to becoming a ketamine clinic CEO will also help address the high rates of burnout plaguing physicians.

What is your biggest lesson learned when raising capital?

Fortunately, we were able to bootstrap the initial costs and didn’t need to raise any outside capital.  We did this intentionally knowing that when there are other investors, it could limit the autonomy of the founders.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Did you notice any type of investor differences while raising money?

N/A

Describe your business model in 10 words or less

Leveraging **specific** ketamine startup knowledge with digital technology.

What tips would you give founders entering fundraising?

1. Be intentional about choosing investors who are aligned with your values and goals.
2. If possible, create the product or service (at least a viable proof-of-concept) before seeking outside investors.
3. Invest your own money first to prove you have “skin in the game.”

 

We’d like to thank Ketamine StartUp for being a part of the Psychedelic Groundbreaker series. Stay tuned for more profiles on leaders in the psychedelic industry, and click here to learn more about Ketamine StartUp.

Would you like to participate in this series? Fill out this form and we’ll follow up with a review of your application.

Tags: Ketamine StartUp
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post

News You Might Have Missed: Oct 18

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.